Montero-Melendez T - Search Results

1

Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells.

Schutters K, Kusters DH, Chatrou ML, Montero-Melendez T, Donners M, Deckers NM, Krysko DV, Vandenabeele P, Perretti M, Schurgers LJ, Reutelingsperger CP. Schutters K, et al. Cell Death Differ. 2013 Jan;20(1):49-56. doi: 10.1038/cdd.2012.107. Epub 2012 Sep 7. Cell Death Differ. 2013. PMID: 22955945 Free PMC article.

2

Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors.

Montero-Melendez T, Dalli J, Perretti M. Montero-Melendez T, et al. Cell Death Differ. 2013 Apr;20(4):567-75. doi: 10.1038/cdd.2012.154. Epub 2012 Dec 7. Cell Death Differ. 2013. PMID: 23222458 Free PMC article.

3

Gapdh gene expression is modulated by inflammatory arthritis and is not suitable for qPCR normalization.

Montero-Melendez T, Perretti M. Montero-Melendez T, et al. Inflammation. 2014 Aug;37(4):1059-69. doi: 10.1007/s10753-014-9829-x. Inflammation. 2014. PMID: 24493325

4

Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation.

Perretti M, Leroy X, Bland EJ, Montero-Melendez T. Perretti M, et al. Trends Pharmacol Sci. 2015 Nov;36(11):737-755. doi: 10.1016/j.tips.2015.07.007. Epub 2015 Nov 2. Trends Pharmacol Sci. 2015. PMID: 26478210 Review.

5

The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties.

Montero-Melendez T, Patel HB, Seed M, Nielsen S, Jonassen TE, Perretti M. Montero-Melendez T, et al. Am J Pathol. 2011 Jul;179(1):259-69. doi: 10.1016/j.ajpath.2011.03.042. Epub 2011 May 10. Am J Pathol. 2011. PMID: 21703408 Free PMC article.

6

Connections in pharmacology: innovation serving translational medicine.

Montero-Melendez T, Perretti M. Montero-Melendez T, et al. Drug Discov Today. 2014 Jul;19(7):820-3. doi: 10.1016/j.drudis.2013.11.022. Epub 2013 Dec 6. Drug Discov Today. 2014. PMID: 24316023 Review.

7

Loss of 15-lipoxygenase disrupts T_reg differentiation altering their pro-resolving functions.

Marques RM, Gonzalez-Nunez M, Walker ME, Gomez EA, Colas RA, Montero-Melendez T, Perretti M, Dalli J. Marques RM, et al. Among authors: montero melendez t. Cell Death Differ. 2021 Nov;28(11):3140-3160. doi: 10.1038/s41418-021-00807-x. Epub 2021 May 27. Cell Death Differ. 2021. PMID: 34040168 Free PMC article.

8

Role of melanocortin receptors in the regulation of gouty inflammation.

Montero-Melendez T, Patel HB, Perretti M. Montero-Melendez T, et al. Curr Rheumatol Rep. 2011 Apr;13(2):138-45. doi: 10.1007/s11926-011-0163-0. Curr Rheumatol Rep. 2011. PMID: 21243457 Review.

9

Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects.

Montero-Melendez T, Gobbetti T, Cooray SN, Jonassen TE, Perretti M. Montero-Melendez T, et al. J Immunol. 2015 Apr 1;194(7):3381-8. doi: 10.4049/jimmunol.1402645. Epub 2015 Feb 27. J Immunol. 2015. PMID: 25725103

10

Melanocortin receptors as novel effectors of macrophage responses in inflammation.

Patel HB, Montero-Melendez T, Greco KV, Perretti M. Patel HB, et al. Front Immunol. 2011 Sep 13;2:41. doi: 10.3389/fimmu.2011.00041. eCollection 2011. Front Immunol. 2011. PMID: 22566831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters